Author

Emily K. Cope

Northern Arizona UniversityORCID 0000-0002-9631-2791Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

Allegra T. AroniD· 1 shared Chloe HermaniD· 1 shared Colin V. Wood· 1 shared Daisy L. Barroso· 1 shared David Hattan· 1 shared Emily M. BorsomiD· 1 shared J. Gregory CaporasoiD· 1 shared Kathryn A Conn· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Allegra T. AronORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintMay 30, 2026

Bacteroides fragilis modulates gut microbiome community composition, frontal cortex gene expression, and fecal and frontal cortex metabolites in a mouse model of Alzheimers disease pathologies

Kathryn A Conn, Olivia Schwartz, Shreya Dikshit…·Emily K. Cope

This study shows that Bacteroides fragilis treatment in AD mice alters gut microbiota, reduces neuroinflammation markers, and normalizes brain metabolites.

DOI 10.64898/2026.05.29.728805

mousebulk RNA-seq

𝕏 PostBluesky